Detalhe da pesquisa
1.
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.
Immunity
; 50(2): 477-492.e8, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737146